Just wondering - what would be the main reason(s) why the FDA should not approve Zircaix?
I am a small cap investor from Germany. I do not know much about Telix, aside that they appear to do a great job looking at the shareprice. I stumbled upon Telix while researching a German company called Heidelberg Pharma from which Telix inlicensed the antibody used in Zircaix. Heidelberg Pharma is entiteld to receive royalties from Telix (20% of Zircaix product sales if I am not mistaken). They did a partial sale of there royalty stream for Zircaix and would receive USD 75m upon Zircaix FDA approval.
PR: Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million - Heidelberg Pharma AG (heidelberg-pharma.com)
Heidelberg Pharma trading at an Mcap of just EUR 120m, EV < 100m. The market appears to price in a high risk of Zircaix not receiving FDA approval.
Happy to hear your thoughts!
Disclosure: I hold a position in Heidelberg Pharma.
Ann: Telix Completes TLX250-CDx (Zircaix) BLA Submission, page-34
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.93 |
Change
0.000(0.00%) |
Mkt cap ! $6.669B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11439 | $22.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.94 | 6123 | 6 |
View Market Depth
| Last trade - 10.06am 17/07/2024 (20 minute delay) ? |
| TLX (ASX) Chart |
Day chart unavailable